Trials / Completed
CompletedNCT00456937
Escitalopram in Schizophrenia in OCD- Open Label Study
Escitalopram in the Treatment of Patient Suffering From Scizophrenia and Obsessive Compulsive Disorder- an Open Label Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- BeerYaakov Mental Health Center · Other Government
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
SSRI's has been demonstrated to be partially effective in schizophrenia and OCD. We therefore suggest that Escitalopram up to 20 mg /d in those patients could be effective in reducing obsessive compulsive symptomatology
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Escitalopram |
Timeline
- Start date
- 2006-07-01
- Primary completion
- 2008-09-01
- Completion
- 2008-09-01
- First posted
- 2007-04-05
- Last updated
- 2009-01-27
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00456937. Inclusion in this directory is not an endorsement.